Based on the HealthEquity Inc stock forecast from 11 analysts, the average analyst target price for HealthEquity Inc is USD 103.55 over the next 12 months. HealthEquity Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of HealthEquity Inc is Slightly Bullish , which is based on 9 positive signals and 5 negative signals. At the last closing, HealthEquity Inc’s stock price was USD 104.25. HealthEquity Inc’s stock price has changed by +5.32% over the past week, +18.99% over the past month and +56.13% over the last year.
No recent analyst target price found for HealthEquity Inc
No recent average analyst rating found for HealthEquity Inc
Company Overview HealthEquity Inc
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah. Read Less
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information...Read More
Frequently Asked Questions About HealthEquity Inc (HQY) Stock
Based on ratings from 11 analysts HealthEquity Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 19 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on HQY's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for HQY is USD 103.55 over the next 12 months. The maximum analyst target price is USD 120 while the minimum anlayst target price is USD 92.
HQY stock's Price/Earning ratio is 85.80.
Our analysis grades HQY stock's Price / Earning ratio at F. This means that HQY stock's Price/Earning ratio is above 61% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this HQY may be a overvalued for its sector.
The last closing price of HQY's stock was USD 104.25.
The most recent market capitalization for HQY is USD 8.99B.
Based on targets from 11 analysts, the average taret price for HQY is projected at USD 103.55 over the next 12 months.
This means that HQY's stock price may go down by -0.67% over the next 12 months.
We can't find any ETFs which contains HealthEquity Inc's stock.
As per our most recent records HealthEquity Inc has 3,126 Employees.
HealthEquity Inc's registered address is 15 West Scenic Pointe Drive, Draper, UT, United States, 84020.
You can get more information about it from HealthEquity Inc's website at https://www.healthequity.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About HealthEquity Inc (HQY) Stock
Based on ratings from 11 analysts HealthEquity Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 19 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on HQY's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for HQY is USD 103.55 over the next 12 months. The maximum analyst target price is USD 120 while the minimum anlayst target price is USD 92.
HQY stock's Price/Earning ratio is 85.80.
Our analysis grades HQY stock's Price / Earning ratio at F. This means that HQY stock's Price/Earning ratio is above 61% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this HQY may be a overvalued for its sector.
The last closing price of HQY's stock was USD 104.25.
The most recent market capitalization for HQY is USD 8.99B.
Based on targets from 11 analysts, the average taret price for HQY is projected at USD 103.55 over the next 12 months.
This means that HQY's stock price may go down by -0.67% over the next 12 months.
We can't find any ETFs which contains HealthEquity Inc's stock.
As per our most recent records HealthEquity Inc has 3,126 Employees.
HealthEquity Inc's registered address is 15 West Scenic Pointe Drive, Draper, UT, United States, 84020.
You can get more information about it from HealthEquity Inc's website at https://www.healthequity.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HQY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
